EARS-Net is based on routine clinical antimicrobial susceptibility data from local and clinical laboratories reported to ECDC by appointed representatives from the Member States.
This report describes and summarises the results of the 2022 external quality assessment (EQA) of antimicrobial susceptibility testing (AST) by clinical laboratories that participate in the European Antimicrobial Resistance Surveillance Network (EARS-Net).
The European Centre for Disease Prevention and Control (ECDC) has previously raised the alarm on the increasing threat of antimicrobial resistance, estimating that over 35 000 people die annually from infections resistant to antibiotics in the European Union (EU), Iceland, and Norway.
This executive summary showcases results derived from 2022 antimicrobial resistance (AMR) data, sourced from invasive isolates reported to both the Central Asian and European Surveillance of Antimicrobial Resistance (CAESAR) network and the European Antimicrobial Resistance Surveillance Network (EARS-Net).
In 2022, for the first time, all European Union/European Economic Area (EU/EEA) countries reported data to the European Antimicrobial Resistance Surveillance Network (EARS-Net).
Infographic providing an overview of the EU progress towards achieving its 2030 antimicrobial resistance targets, also available in an editable format and for all EU countries.